CRST is a contract research organization (CRO) that conducts clinical studies for the pharmaceutical industry and for other customers. CRST is run by experienced specialists with in-depth understanding of basic and clinical pharmacology and drug development, especially in therapeutic areas such as disorders of the central nervous system and metabolic and cardiovascular diseases.
CRST’s core expertise lies in the understanding of disease mechanisms. Specialists from different fields participate in CRST’s operations as principal investigators and scientific consultants. Thanks to its close cooperation with Turku PET Centre, CRST is equipped to perform clinical proof-of-concept studies involving PET imaging. CRST’s clients include many leading Finnish, Nordic and multinational companies, also most of the biggest Pharma companies.
As a customer-oriented service provider, CRST has enjoyed excellent customer satisfaction during its history. Over 90 % of customers have returned with another project. CRST’s services include clinical study design, study conduct and reporting and regulatory affairs.
CRST was established in 1995 by Professors in Pharmacology and Clinical Pharmacology, Mika Scheinin and Risto Huupponen, and Professor of Biostatistics, Juhani Tuominen. They wanted to ensure the competitiveness of the University of Turku in clinical contract research at a time when compatibility with good clinical practice guidelines (GCP) became a general requirement.
Since then, CRST has evolved as a recognised service provider for the pharmaceutical industry in Northern Europe and elsewhere. CRST was spun out from the University of Turku in 2014 and is now a private company, with the University of Turku as a minority shareholder.